Microvascular remodeling and large artery stiffness are key determinants of cardiovascular hemodynamics and can now be studied with new non-invasive methods. Our objective was to study the ...
Seventeen months after a refillable port delivery system (PDS) with ranibizumab had been recalled, researchers found that a high percentage of patients with neovascular age-related macular ...
Timothy Kraft, PhD, is an expert in retinal physiology who has studied the function and biophysics of retinal photoreceptors for almost 30 years. Kraft has worked with fellow UAB researcher Dr. Erik ...
Deep machine learning can extract and quantify several risk factors for cardiovascular disease (CVD) from photographs of the retinal fundus, according to findings published online February 19 in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A growing body of evidence has demonstrated the ...
Side-view of the human eye, viewed approximately 90° temporal. Image by Paul Savage. CC BY 2.0 Side-view of the human eye, viewed approximately 90° temporal. Image by Paul Savage. CC BY 2.0 Drug ...
Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
New seven-year data from the LADDER study show Contivue with Susvimo provides good visual outcomes with stable retinal anatomy over the longer term 2 With up to two refills per year, Contivue with ...
Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications. A combination treatment ...
4D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all ...